Spectrum Pharmaceuticals
SPPI
#7915
Rank
NZ$0.36 B
Marketcap
$1.76
Share price
0.00%
Change (1 day)
21.39%
Change (1 year)

P/E ratio for Spectrum Pharmaceuticals (SPPI)

P/E ratio on October 3, 2023 (TTM): -2.86

According to Spectrum Pharmaceuticals 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -2.86111. At the end of 2022 the company had a P/E ratio of -0.8605.

P/E ratio history for Spectrum Pharmaceuticals from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.8605-29.54%
2021-1.22-53.45%
2020-2.62-26.5%
2019-3.57-52.69%
2018-7.54-57.01%
2017-17.5268.35%
2016-4.76-39.17%
2015-7.83-17.51%
2014-9.498.34%
2013-8.76-226.99%
20126.90

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-8.56 199.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-57.0 1,893.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.4030-85.91%๐Ÿ‡บ๐Ÿ‡ธ USA
8.55-398.96%๐Ÿ‡บ๐Ÿ‡ธ USA
14.8-618.28%๐Ÿ‡บ๐Ÿ‡ธ USA
39.6-1,484.79%๐Ÿ‡บ๐Ÿ‡ธ USA
27.9-1,074.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
11.0-485.04%๐Ÿ‡บ๐Ÿ‡ธ USA
13.8-581.99%๐Ÿ‡บ๐Ÿ‡ธ USA
9.70-439.06%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.